Four Additional Sites Confirmed for ETF Field Testing

The company has confirmed another four test sites for the pre-production version of the ETF. This brings the total to nine in the US and Canada. This current mix of academic medical centers, hospitals, and clinics will provide comprehensive clinical and market feedback as we move forward to commercial launch.